The online version of this article (https://doi.org/10.1186/s12978-017-0437-8) contains supplementary material, which is available to authorized users.
Maternal sepsis is the underlying cause of 11% of all maternal deaths and a significant contributor to many deaths attributed to other underlying conditions. The effective prevention, early identification and adequate management of maternal and neonatal infections and sepsis can contribute to reducing the burden of infection as an underlying and contributing cause of morbidity and mortality. The objectives of the Global Maternal Sepsis Study (GLOSS) include: the development and validation of identification criteria for possible severe maternal infection and maternal sepsis; assessment of the frequency of use of a core set of practices recommended for prevention, early identification and management of maternal sepsis; further understanding of mother-to-child transmission of bacterial infection; assessment of the level of awareness about maternal and neonatal sepsis among health care providers; and establishment of a network of health care facilities to implement quality improvement strategies for better identification and management of maternal and early neonatal sepsis.
This is a facility-based, prospective, one-week inception cohort study. This study will be implemented in health care facilities located in pre-specified geographical areas of participating countries across the WHO regions of Africa, Americas, Eastern Mediterranean, Europe, South East Asia, and Western Pacific. During a seven-day period, all women admitted to or already hospitalised in participating facilities with suspected or confirmed infection during any stage of pregnancy through the 42nd day after abortion or childbirth will be included in the study. Included women will be followed during their stay in the facilities until hospital discharge, death or transfer to another health facility. The maximum intra-hospital follow-up period will be 42 days.
GLOSS will provide a set of actionable criteria for identification of women with possible severe maternal infection and maternal sepsis. This study will provide data on the frequency of maternal sepsis and uptake of effective diagnostic and therapeutic interventions in obstetrics in different hospitals and countries. We will also be able to explore links between interventions and maternal and perinatal outcomes and identify priority areas for action.
Dolea C, Stein C. Global burden of maternal sepsis in the year 2000. Evidence and Information for Policy (EIP), World Health Organization; 2003. Avilable at http://www.who.int/healthinfo/statistics/bod_maternalsepsis.pdf. Accessed 8 Dec 2017.
Bonet M, Nogueira Pileggi V, Rijken MJ, Coomarasamy A, Lissauer D, Souza JP, Gülmezoglu AM, The Global Maternal and Neonatal Sepsis Initiative Working Group, Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017;14(1):67.
WHO, Statement on maternal sepsis. 2016. Available at http://apps.who.int/iris/bitstream/10665/254608/1/WHO-RHR-17.02-eng.pdf?ua=1. Accessed 8 Dec 2017.
Edwards SE, et al. Modified obstetric early warning scoring systems (MOEWS): validating the diagnostic performance for severe sepsis in women with chorioamnionitis. Am J Obstet Gynecol. 2015;212(4):536.e1–8. CrossRef
WHO, Monitoring emergency obstetric care: a handbook. 2009. Available at http://apps.who.int/iris/bitstream/10665/44121/1/9789241547734_eng.pdf. Accessed 8 Dec 2017.
CRITICAL APPRAISAL SKILLS PROGRAMME (CASP): Making Sense of Evidence 12 Questions to Help You Make Sense of a Cohort Study. Accesible at http://media.wix.com/ugd/dded87_7e983a320087439e94533f4697aa109c.pdf.
Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol. 2012 Sep;120(3):689–706.
Albright CM, Ali TN, Lopes V, Rouse DJ, Anderson BL.The Sepsis in Obstetrics Score: a model to identify risk of morbidity from sepsis in pregnancy. Am J Obstet Gynecol. 2014 Jul;211(1):39.e1–8.
Souza JP, Gϋlmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, Costa MJ, Fawole B, Mugerwa Y, Nafiou I, Neves I, Moving beyond essential interventions for reduction of maternal mortability (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. The Lancet. 2013;381(9879):1747–55.
- The global maternal sepsis study and awareness campaign (GLOSS): study protocol
Joao Paulo Souza
A. Metin Gülmezoglu
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
e.Med Kampagnen-Visual, Mail Icon II